TUSC2 has pro-apoptotic activity in human lung cancer cells through the regulation of the protein kinases EGFR, PDGFR, AKT, c-ABL, and c-KIT [3,10], through the activation of the STAT1 signal pathway and through regulation of the P53 protein [26]. This evidence concerns the gene ABL1 and lung carcinoma.